Position in OCUL
as of Jun 30, 2026
· filed Aug 14, 2026
Position Value
$2,269,136
+$1,314,008 QoQ
Shares Held
231,073
+104.9% QoQ
Ownership
0.105%
of shares outstanding
% of Portfolio
0.00%
of 13F equity value
Holder Rank
#72
of 257 holders
Holding Since
Mar 2020
26 quarters on record
Voting authority
Sole 86%
Shared 0%
None 14%
Common Shares in OCUL Over Time
Shares Held
Position Value (USD)
Derivatives in OCUL
reported options exposure · as of Mar 31, 2021CallValue
$341,328
CallShares
20,800
PutValue
$551,376
PutShares
33,600
Notional value of option positions as reported on Form 13F. Calls and puts are disclosed separately and do not net against the common-share stake above.
Position in Biotechnology
Healthcare · as of Jun 30, 2026WELLS FARGO & COMPANY/MN holds $1,567,528,481 across 417 Biotechnology names. OCUL ranks #91 (0.1% of the industry book) .
| # | Ticker | Company | Shares | Value (USD) | Open |
|---|---|---|---|---|---|
| 1 | VRTX |
Vertex Pharmaceuticals Inc / Ma
|
749,528 | $372,313,040 | |
| 2 | HALO |
Halozyme Therapeutics, Inc.
|
1,390,428 | $108,828,797 | |
| 3 | ALNY |
Alnylam Pharmaceuticals, Inc.
|
310,047 | $93,333,446 | |
| 4 | REGN |
Regeneron Pharmaceuticals, Inc.
|
140,802 | $87,795,677 | |
| 5 | EXEL |
Exelixis, Inc.
|
717,840 | $39,057,673 | |
| 6 | RVMD |
Revolution Medicines, Inc.
|
178,780 | $33,481,916 | |
| 7 | ARGX |
Argenx SE
|
34,453 | $31,964,458 | |
| 8 | INCY |
Incyte Corp
|
255,064 | $28,914,053 |
All Filings in OCUL
Export CSV
28 filing rows on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-06-30 | $2,269,136 | 231,073 | Shares | Defined | 2026-08-14 | |
| 2026-03-31 | $955,128 | 112,766 | Shares | Defined | 2026-05-11 | |
| 2025-12-31 | $3,098,395 | 255,222 | Shares | Defined | 2026-02-13 | |
| 2025-09-30 | $1,529,659 | 130,852 | Shares | Defined | 2025-11-13 | |
| 2025-06-30 | $688,112 | 74,150 | Shares | Defined | 2025-08-14 | |
| 2025-03-31 | $564,739 | 77,045 | Shares | Defined | 2025-05-13 | |
| 2024-12-31 | $633,736 | 74,208 | Shares | Defined | 2025-02-13 | |
| 2024-09-30 | $3,970,906 | 456,426 | Shares | Defined | 2024-11-13 | |
| 2024-06-30 | $351,021 | 51,319 | Shares | Defined | 2024-08-13 | |
| 2024-03-31 | $327,954 | 36,039 | Shares | Defined | 2024-05-10 | |
| 2023-12-31 | $99,025 | 22,203 | Shares | Defined | 2024-02-09 | |
| 2023-09-30 | $53,772 | 17,125 | Shares | Defined | 2023-11-13 | |
| 2023-06-30 | $178,087 | 34,513 | Shares | Defined | 2023-08-15 | |
| 2023-03-31 | $93,748 | 17,789 | Shares | Defined | 2023-05-12 | |
| 2022-12-31 | $5,479 | 1,950 | Shares | Defined | 2023-02-13 | |
| 2022-09-30 | $27,024 | 6,512 | Shares | Defined | 2022-11-14 | |
| 2022-06-30 | $28,610 | 7,117 | Shares | Defined | 2022-08-12 | |
| 2022-03-31 | $80,288 | 16,220 | Shares | Defined | 2022-05-16 | |
| 2021-12-31 | $292,990 | 42,036 | Shares | Defined | 2022-02-14 | |
| 2021-09-30 | $564,860 | 56,486 | Shares | Defined | 2021-11-15 | |
| 2021-06-30 | $1,025,369 | 72,311 | Shares | Defined | 2021-08-16 | |
| 2021-03-31 | $341,328 | 20,800 | Call | Defined | 2021-05-13 | |
| 2021-03-31 | $551,376 | 33,600 | Put | Defined | 2021-05-13 | |
| 2021-03-31 | $8,784,797 | 535,332 | Shares | Defined | 2021-05-13 | |
| 2020-12-31 | $6,264,709 | 302,643 | Shares | Defined | 2021-02-09 | |
| 2020-09-30 | $1,269,430 | 166,811 | Shares | Defined | 2020-11-05 | |
| 2020-06-30 | $568,097 | 68,199 | Shares | Defined | 2020-08-13 | |
| 2020-03-31 | $261,993 | 52,928 | Shares | Defined | 2020-05-14 | |
| No filing history on record for this holder in this stock. | ||||||